BDE-36431-61121
2 vaccinations
9 coded responses
27 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 880 / NM
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Moderna
-
2021-01-22
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-24
- 2021-01-25
-
2021-01-26
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph node swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Lymph node pain, Lymphadenopathy — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: Bruise at inj site; swollen/ sore lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Fatigue, Injection site pain, Injection site swelling, Injection site warmth, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: 7.5 days post injection, delayed hypersensitivity rxn on injection arm. Significant swelling, heat, pain. Body aches, fatigue. Lasted approximately 36 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-19
-
2021-02-26
Dose 2 — Moderna
-
2021-02-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-01
Survey response — days 1–6 daily, dose 2MedDRA: Herpes simplex, Hypoaesthesia, Pre-existing disease — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe outbreak of HSV labialis requiring treatment. Also, some mild facial numbness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Herpes simplex, Hypoaesthesia, Pre-existing disease — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessFree text: Continuing treatment for HSV on face. Mild facial numbness continues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-05
- 2021-03-12
- 2021-03-20
- 2021-03-26
-
2021-04-04
Survey response — day 35, dose 2MedDRA: Fatigue, Pain, Stress, Trigeminal neuropathy — Feeling: Good · Be unable to do your normal daily activitiesFree text: Facial neuropathy persists and is worsened by stress. Also, experienced another day of severe body aches and fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-05-28
- 2021-08-29
- 2021-09-16
- 2021-09-17
-
2021-09-17
Callback requested for11:00AM ET
-
2022-02-26
Survey response — 12 months, dose 2MedDRA: Suspected COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Jan 2021, suspected case of COVID 19, but never able to confirm, no test available at the time.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-26 | Moderna |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Bruise at injection site
Systemic reaction (other): Lymph node swelling
Systemic reaction (other): Bruise at inj site; swollen/ sore lymph nodes
Release 3 — day 7, dose 1
Systemic reaction (other): Swollen lymph nodes
Release 3 — day 14, dose 1
Symptoms: 7.5 days post injection, delayed hypersensitivity rxn on injection arm. Significant swelling, heat, pain. Body aches, fatigue. Lasted approximately 36 hours
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Severe outbreak of HSV labialis requiring treatment. Also, some mild facial numbness.
Systemic reaction (other): Continuing treatment for HSV on face. Mild facial numbness continues.
Release 6 — day 35, dose 2
Symptoms: Facial neuropathy persists and is worsened by stress. Also, experienced another day of severe body aches and fatigue.
Release 11 — 12 months, dose 2
Symptoms: Jan 2021, suspected case of COVID 19, but never able to confirm, no test available at the time.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Stress | ✓ | ✓ | ✓ |
| SD | Suspected COVID-19 | · | · | ✓ |
| SD | Trigeminal neuropathy | ✓ | ✓ | ✓ |
| SRO | Herpes simplex | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release